Levin Capital Strategies’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-30,000	Closed	-$128K	–	247
2023 Q2	$128K	Buy	+30,000	New	+$128K	0.01%	220